|
|
|
LifeScienceHistory.com - Check us out on Instagram
Washington Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing WashingtonLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Impel NeuroPharma
| | | Phone: | (206) 568-1466 | Fax: | (206) 726-1217 | Year Established: | 2008 | Main Contact: | John Hoekman, Co-Founder & Interim CEO | | Other Contacts: | Mike Malafronte, VP, Quality Assurance Scott Youmans, Senior VP, Engineering Vita Conforti, Director of Legal Affairs Stephen Shrewsbury, CMO
| | Company Description | Impel NeuroPharma Inc is a biopharmaceutical company specializing developing enhanced CNS products based on its proprietary Precision Olfactory Delivery (POD) technology.
Impel is committed to improving the delivery of CNS therapeutics and is rapidly growing its pipeline of internal products through its INP-101, INP-102 and INP-104 programs. The Company’s INP-104 product candidate is in late-stage development to improve the treatment of drug-resistant migraine in patients who have failed front-line triptan therapy. INP-101 is in clinical development to improve the management of pain in patients who have difficulty tolerating traditional systemically administered opioids yet require reliable and rapid analgesia. Its novel Alzheimers Disease product candidate, INP-102, is currently in multiple later-stage clinical trials, including Phase 2 and Phase 3a studies. | |
|
|
|
|
|